| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61126-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12030-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12077-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12035-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20161-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35254-10ug | |||
| Carrier-Free | NBP2-35254-1mg | |||
| Carrier-Free | NBP2-35254-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35121-10ug | |||
| Carrier-Free | NBP2-35121-1mg | |||
| Carrier-Free | NBP2-35121-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34998-1mg | |||
| Carrier-Free | NBP2-34998-100ug | |||
| Carrier-Free | NBP2-34998-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34950-10ug | |||
| Carrier-Free | NBP2-34950-1mg | |||
| Carrier-Free | NBP2-34950-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35228-10ug | |||
| Carrier-Free | NBP2-35228-1mg | |||
| Carrier-Free | NBP2-35228-500ug | |||
![Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.](http://images.novusbio.com/fullsize/IL-4-Antibody-V17P1B4-B12-Ovalbumine-Azide-and-BSA-Free-Western-Blot-NBP2-61126-img0001.jpg "Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.")
![Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD53-Antibody-161-2-53-2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12077-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-MM17F3-Chimeric-Flow-Cytometry-NBP3-12035-img0001.jpg "Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![Flow Cytometry: FCAR/CD89 Antibody (14A8 (14.1)) - Chimeric - Azide and BSA Free [NBP3-20161] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or the rabbit IgG version of 14A8 (14.1) (NBP3-20161, blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-20161_rabbit-fcar-cd89-mab-14a8-14-1-chimeric-azide-bsa-free-2742023924255.png "Flow Cytometry: FCAR/CD89 Antibody (14A8 (14.1)) - Chimeric - Azide and BSA Free [NBP3-20161] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or the rabbit IgG version of 14A8 (14.1) (NBP3-20161, blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]](http://images.novusbio.com/fullsize/Recombinant-Human-Lymphotoxin-alpha-TNF-beta-Protein-SDS-Page-NBP2-61307-img0002.jpg "SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]")
![SDS-Page: Rat IL-6 Protein [NBP2-35254]](http://images.novusbio.com/fullsize/Rat-IL-6-Protein-SDS-Page-NBP2-35254-img0001.jpg "SDS-Page: Rat IL-6 Protein [NBP2-35254]")
![SDS-Page: Mouse IL-21 Protein [NBP2-35121]](http://images.novusbio.com/fullsize/Mouse-IL-21-Protein-SDS-Page-NBP2-35121-img0001.jpg "SDS-Page: Mouse IL-21 Protein [NBP2-35121]")
![SDS-Page: Equine IL-2 Protein [NBP2-34950]](http://images.novusbio.com/fullsize/Equine-IL-2-Protein-SDS-Page-NBP2-34950-img0001.jpg "SDS-Page: Equine IL-2 Protein [NBP2-34950]")
![SDS-Page: Porcine IL-1 beta/IL-1F2 Protein [NBP2-35228]](http://images.novusbio.com/fullsize/Porcine-IL-1-beta-IL-1F2-Protein-SDS-Page-NBP2-35228-img0001.jpg "SDS-Page: Porcine IL-1 beta/IL-1F2 Protein [NBP2-35228]")
![SDS-Page: Recombinant Rat IL-10 Protein [NBP2-61341]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-10-Protein-SDS-Page-NBP2-61341-img0002.jpg "SDS-Page: Recombinant Rat IL-10 Protein [NBP2-61341]")